Characterizing the Genetics and Epigenetics of Linear Morphea

Dawn Eichenfield M.D.

Morphea is an inflammatory skin disease that can be debilitating and disfiguring. Developing a better understanding of this disease is the first step toward better pharmacological treatments and preventive strategies. Scientists have only recently recognized the disease relevance of noncoding regions of the genome and developed the ability to study their effects. Our research aims to uncover the genetic causes of morphea by studying noncoding regions.

— Dawn Z. Eichenfield, MD, PhD

 

Related Articles

Crystal Aguh M.D.

Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…

Read More

Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus

Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…

Read More

Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy

Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…

Read More